Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...
Researchers at the Van Andel Institute suggest that the routes cancer cells use to process different nutrients deeply influence cell behavior. They discovered an alternate, or non-canonical, path by ...
A new strategy developed by Professor Nathan Gianneschi grabs cancer-driving proteins and directs them to the cell’s disposal ...
A fleeting DNA fold called i‑DNA can switch cancer‑related genes on and off, revealing a hidden structural weak point that ...
A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...
One way cancer specialists detect the disease is by examining cells and bodily fluids under a microscope, a time-consuming ...
Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results